Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 31 04:00PM ET
2.37
Dollar change
-0.01
Percentage change
-0.42
%
IndexRUT P/E- EPS (ttm)-1.19 Insider Own33.00% Shs Outstand95.64M Perf Week-2.07%
Market Cap230.21M Forward P/E- EPS next Y-1.84 Insider Trans0.00% Shs Float65.08M Perf Month-10.23%
Income-112.77M PEG- EPS next Q-0.42 Inst Own50.06% Short Float7.40% Perf Quarter-23.55%
Sales88.46M P/S2.60 EPS this Y-3.10% Inst Trans0.94% Short Ratio10.93 Perf Half Y-15.05%
Book/sh0.63 P/B3.78 EPS next Y-30.09% ROA-38.89% Short Interest4.81M Perf Year17.33%
Cash/sh2.45 P/C0.97 EPS next 5Y2.70% ROE-115.00% 52W Range1.87 - 4.27 Perf YTD-29.46%
Dividend Est.- P/FCF1096.23 EPS past 5Y-12.83% ROI-81.46% 52W High-44.50% Beta0.51
Dividend TTM- Quick Ratio2.48 Sales past 5Y53.46% Gross Margin93.66% 52W Low26.74% ATR (14)0.13
Dividend Ex-Date- Current Ratio2.48 EPS Y/Y TTM-413.27% Oper. Margin-133.92% RSI (14)34.97 Volatility3.73% 4.21%
Employees330 Debt/Eq1.38 Sales Y/Y TTM-43.55% Profit Margin-127.48% Recom1.00 Target Price14.00
Option/ShortYes / Yes LT Debt/Eq1.28 EPS Q/Q-2.28% Payout- Rel Volume0.61 Prev Close2.38
Sales Surprise68.65% EPS Surprise21.32% Sales Q/Q29.78% EarningsAug 05 AMC Avg Volume440.30K Price2.37
SMA20-5.12% SMA50-14.36% SMA200-20.62% Trades Volume266,784 Change-0.42%
Date Action Analyst Rating Change Price Target Change
Jan-04-23Initiated H.C. Wainwright Buy $15
Jan-07-22Initiated Cantor Fitzgerald Overweight $24
May-18-21Initiated BTIG Research Buy $40
Aug-04-20Initiated William Blair Outperform
Aug-04-20Initiated Piper Sandler Overweight $30
Aug-04-20Initiated BofA Securities Buy $20
Oct-24-24 08:00AM
Oct-17-24 08:00AM
Oct-15-24 08:05AM
Oct-03-24 04:30PM
Sep-27-24 04:30PM
04:12AM Loading…
Sep-17-24 04:12AM
Sep-16-24 08:00AM
Sep-05-24 09:00AM
Sep-04-24 04:05PM
Aug-29-24 04:05PM
Aug-05-24 09:55PM
05:55PM
04:05PM
Jul-19-24 12:00PM
Jul-01-24 04:05PM
04:05PM Loading…
Jun-03-24 04:05PM
May-14-24 09:53PM
05:08PM
04:05PM
May-09-24 09:00AM
May-02-24 06:22AM
06:04AM
May-01-24 09:30PM
05:42AM
Apr-18-24 08:00AM
Apr-17-24 09:00AM
Apr-08-24 12:00PM
Apr-01-24 04:05PM
Mar-25-24 04:05PM
Mar-19-24 04:05PM
04:05PM Loading…
Mar-13-24 04:05PM
Mar-07-24 10:53PM
10:45PM
06:55PM
04:07PM
Mar-04-24 04:05PM
Jan-04-24 08:00AM
Dec-10-23 12:00PM
Nov-17-23 01:08PM
Nov-09-23 04:05PM
Nov-07-23 08:00AM
Nov-02-23 10:00AM
09:01AM
Oct-16-23 12:00PM
Oct-09-23 04:30PM
Oct-03-23 05:00PM
Sep-05-23 08:00AM
Aug-10-23 06:02AM
Aug-08-23 05:40PM
04:05PM
Aug-07-23 09:01AM
09:00AM
Jul-31-23 08:23AM
Jul-05-23 08:00AM
Jun-26-23 08:00AM
Jun-01-23 08:00AM
May-23-23 08:00AM
May-22-23 08:00AM
May-18-23 08:00AM
May-11-23 06:11AM
May-10-23 12:00PM
May-09-23 07:05PM
04:05PM
May-02-23 04:30PM
May-01-23 08:00AM
Apr-17-23 06:48AM
Apr-13-23 08:00AM
Apr-11-23 04:05PM
08:00AM
Apr-03-23 07:09AM
Mar-09-23 06:05PM
04:05PM
Mar-01-23 08:00AM
Feb-22-23 08:00AM
Feb-21-23 06:50AM
Feb-15-23 08:50AM
Feb-14-23 08:00AM
Feb-08-23 08:00AM
Jan-31-23 04:05PM
Jan-27-23 08:50AM
Jan-25-23 11:16AM
Jan-10-23 08:50AM
Jan-04-23 02:51PM
Dec-15-22 08:50AM
Dec-11-22 10:30AM
Dec-06-22 09:55AM
06:00AM
Nov-10-22 06:45PM
04:05PM
Nov-08-22 08:00AM
Nov-03-22 09:00AM
09:00AM
Oct-25-22 06:11AM
Oct-05-22 08:09AM
Sep-14-22 06:57AM
Sep-07-22 04:05PM
Aug-11-22 04:05PM
Aug-08-22 04:05PM
Aug-04-22 08:00AM
07:00AM
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.